PALISADE CAPITAL MANAGEMENT, LP - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is and the CUSIP is 462222AB6. A total of 16 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
PALISADE CAPITAL MANAGEMENT, LP ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,483,300
-44.9%
2,614,000
-44.9%
0.07%
-42.5%
Q2 2023$4,503,000
+3.0%
4,740,0000.0%0.12%
+1.7%
Q1 2023$4,369,806
+1.4%
4,740,0000.0%0.12%
+1.7%
Q4 2022$4,307,373
-1.2%
4,740,0000.0%0.12%
-6.5%
Q3 2022$4,361,000
+4.6%
4,740,0000.0%0.12%
+9.7%
Q2 2022$4,168,000
-34.1%
4,740,000
-32.6%
0.11%
-22.1%
Q1 2022$6,320,000
+89.7%
7,032,000
+90.1%
0.14%
+116.4%
Q4 2021$3,332,0003,700,0000.07%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Penn Mutual Asset Management 2,756,000$2,621,7832.46%
Sonora Investment Management Group, LLC 18,573,000$17,727,7271.52%
PALISADE CAPITAL MANAGEMENT, LP 2,614,000$2,483,3000.07%
Kohlberg Kravis Roberts & Co. L.P. 510,000$487,7130.02%
PINNACLE ASSOCIATES LTD 280,000$267,1540.01%
MACQUARIE GROUP LTD 3,903,000$3,732,0000.01%
HighTower Advisors, LLC 2,453,000$2,355,0000.00%
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 2,500,000$2,357,5000.00%
CITIGROUP INC 1,754,000$1,668,5800.00%
MORGAN STANLEY 7,090,000$6,717,7750.00%
View complete list of IONIS PHARMACEUTICALS INC shareholders